Simple strategy could lead to a 'universal' flu vaccine

October 2, 2017, Rockefeller University
Researchers are working on a vaccine they hope will protect against many flu strains, including pandemic-inducing bird viruses like the one shown above. Credit: Rockefeller University

It's that time of year again: Temperatures drop, sleeves go up, and the needles come out. If scientists at The Rockefeller University have their way, however, the annual ritual of the flu shot could become obsolete.

A team based in Jeffrey V. Ravetch's lab has devised a strategy for improving existing flu vaccines to better protect against these ever-mutating viruses. If successful, their work could translate into fewer flu shots.

"We have a simple, direct strategy for developing a broadly protective influenza ," says Taia T. Wang, who conducted the research as an instructor in clinical investigation in Ravetch's lab.

Current vaccines protect against three or four specific of flu that experts predict will be in circulation during a particular flu season. However, in new experiments, the researchers found they could alter such a vaccine to defend mice against two additional strains, of which one has the potential to erupt into a global outbreak. The researchers say this is an important step toward a single, "universal" vaccine that protects against all the myriad viruses that cause flu.

Shots in the dark

A serious and sometimes fatal disease, flu typically circulates in fall and winter. While outbreaks may be predictable, the cause of the disease is not. Flu viruses are numerous, diverse, and constantly changing, making them difficult targets for vaccines. That's because the vaccines contain proteins from specific viral strains, which prime the immune system to respond to the real thing—namely, whole viruses from the very same strains.

What's more, seasonal vaccines offer little or no protection against a much rarer, more dramatic disease: pandemic flu, which arises when viruses residing in animals, particularly birds, acquire the ability to spread rapidly between people.

The researchers believe it may be possible to provide broad protection against most seasonal strains, and perhaps even , by adding a special ingredient to current vaccines.

In earlier experiments, the researchers found that soon after receiving a flu shot, the people who responded best to the vaccine produced high levels of immune proteins called antibodies with an important change to their structure. Rather than directly fighting the , these altered antibodies act as signals, prompting the immune system to produce other antibodies that are especially good at latching onto—and disabling—the pathogen.

Fewer shots, less sickness

Wang and Jad Maamary, a former postdoc in the lab, bolstered a regular with similarly altered antibodies. In recent experiments, they found this new and improved vaccine protected mice against viruses it did not contain, including a strain of the seasonal virus known as H1N1 and a strain of H5N1, a bird virus with the potential to cause pandemic disease.

In hopes of expanding the coverage afforded by their altered vaccines and so making annual shots a thing of the past, the researchers now plan to test their approach against yet more branches of the vast flu family.

"A very reasonable goal might be to provide protection over five to ten flu seasons, with some protection against pandemic strains as well," says Wang, who is now an assistant professor at Stanford University. "But a true universal influenza vaccine may also be attainable—and that is, of course, our objective."

The implications of the research, which was described recently in the Proceedings of the National Academy of Science, go beyond flu. "It may be possible to exploit the same signaling pathway to improve other vaccines, including those that prevent some bacterial infections," says Ravetch, the Theresa and Eugene M. Lang Professor.

Explore further: New DNA-based strategy shows promise against a range of influenza viruses

More information: Jad Maamary et al. Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization, Proceedings of the National Academy of Sciences (2017). DOI: 10.1073/pnas.1707950114

Related Stories

New DNA-based strategy shows promise against a range of influenza viruses

July 6, 2017
A novel, synthetic, DNA-based strategy to provide protection against a broad array of influenza viruses has been developed in preclinical models by scientists at The Wistar Institute, MedImmune (the global biologics research ...

Discovery points to a new path toward a universal flu vaccine

July 2, 2015
Flu vaccines can be something of a shot in the dark. Not only must they be given yearly, there's no guarantee the strains against which they protect will be the ones circulating once the season arrives.

UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza

March 29, 2016
Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza ...

Intranasal flu vaccine produces long-lasting immune response in mice

July 19, 2016
Intranasal flu vaccines may be able to provide long-lasting protection against pandemic flu strains, according to a new study from immunologists at Columbia University Medical Center (CUMC).

Study suggests potential hurdle to universal flu vaccine development may be overcome

August 15, 2012
In the quest for a universal influenza vaccine—one that elicits broadly neutralizing antibodies that can protect against most or all strains of flu virus—scientists have faced a sobering question: Does pre-existing ...

Stepping closer to a universal flu vaccine

October 7, 2016
Researchers at McMaster University and two American universities have taken another step closer to developing a much more effective, "one-punch" universal flu vaccine.

Recommended for you

Basic research in fruit flies leads to potential drug for diseases afflicting millions

July 13, 2018
River blindness and elephantiasis are debilitating diseases caused by parasitic worms that infect as many as 150 million people worldwide. They are among the "neglected tropical diseases" for which better treatments are desperately ...

Light based cochlear implant restores hearing in gerbils

July 12, 2018
A team of researchers with members from a variety of institutions across Germany has developed a new type of cochlear implant—one based on light. In their paper published in the journal Science Translational Medicine, the ...

Researchers discover gene that controls bone-to-fat ratio in bone marrow

July 12, 2018
In an unexpected discovery, UCLA researchers have found that a gene previously known to control human metabolism also controls the equilibrium of bone and fat in bone marrow as well as how an adult stem cell expresses its ...

Intensive care patients' muscles unable to use fats for energy

July 12, 2018
The muscles of people in intensive care are less able to use fats for energy, contributing to extensive loss of muscle mass, finds a new study co-led by UCL, King's College London and Guy's and St Thomas' NHS Foundation Trust.

Blood biomarker can help predict disease progression in patients with COPD

July 12, 2018
Some patients with COPD demonstrate signs of accelerated aging. In a new study published in the journal CHEST researchers report that measuring blood telomeres, a marker of aging of cells, can be used to predict future risk ...

Rogue molecules provoke out-of-control scar tissue, strangle organs

July 12, 2018
Normal scar tissue forms to heal an internal wound and quietly retreats when the job is done. But in many common diseases—kidney, liver and lung fibrosis—the scar tissue goes rogue and strangles vital organs. These diseases ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.